!
tumorigenic state while stem cell-derived clones expanded rapidly leading in time to basal
cell carcinoma formation”, comments Adriana Sánchez-Danés, the first author of the study.
In collaboration with Pr.Benjamin D Simons, Cavendish Laboratory and the Gurdon Institute,
University of Cambridge, UK, they developed a mathematical model of clonal evolution,
which defines for the first time, at the single cell resolution, the quantitative dynamics of
tumor initiation from the activation of the oncogene to the development of invasive tumours.
Interestingly, they found that oncogenic activation in progenitors lead to the generation of
pre-tumorigenic lesions that are frozen and cannot progress into invasive tumors. In contrast,
oncogene expression in stem cells resulted in a more rapid clonal expansion characterized
by an increase in self-renewing divisions combined with a higher resistance to cell death, and
leading in turn to the development of clones that progress into invasive tumors. These data
demonstrate that targeting stem cells, which reside at the top of the cellular hierarchy in the
skin epidermis, was necessary for tumor formation.
Altogether, this study provides important insights into the changes in the cellular dynamics
that lead to tumor formation and demonstrates that the capacity of oncogene expressing
cells to induce tumor formation depends on the specific clonal dynamics of the cancer cell of
origin. “This new finding not only demonstrates that the cancer cell of origin matters, but also
that stem cells are particularly sensitive to tumor initiation due to their natural ability to self-
renew and their resistance to oncogene mediated cell death. This mode of tumour
development suggests that therapy promoting differentiation or apoptosis should be effective
in the treatment of basal cell carcinomas, and should lead to tumour regression and prevent
tumour relapse.” explains Cédric Blanpain, the senior author of this Nature paper.
This work was supported by the FNRS, TELEVIE, a research grant from the Fondation
Contre le Cancer, the ULB fondation, Wellcome Trust and Trinity College Cambridge, the
foundation Bettencourt Schueller, the foundation Baillet Latour, the European Research
Council (ERC).
Journalists should credit Nature as the source of stories covered.
Adriana Sánchez-Danés*, Edouard Hannezo*, Jean-Christophe Larsimont, Mélanie Liagre, Khalil
Kass Youssef, Benjamin D Simons# and Cédric Blanpain#.
Defining the clonal dynamics leading to mouse skin tumour initiation
Nature, 2016. DOI 10.1038/nature19069
* denotes co-first authors # Corresponding authors
Contacts :
Cédric Blanpain, MD, PhD
Welbio, Interdisciplinary Research Institute (IRIBHM)
U-CRC, Université Libre de Bruxelles (ULB)
Tél. : 32-2-555 4175 ou 32-2- 555 4190
Email: Cedric.Blanpain@ulb.ac.be
Lab Website: http://blanpainlab.ulb.ac.be/index.htm